Does topical application of transexamic acid reduce postoperative bleeding in coronary artery bypass graft surgery?
Phase 4
- Conditions
- bleeding.Other postprocedural disorders of circulatory system, not elsewhere classified
- Registration Number
- IRCT2016071628945N1
- Lead Sponsor
- investigator
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
patients undergoing CABG surgery alone; interrupting aspirin three days and Plavix at least five days before surgery; lack of consuming any other anticoagulant drugs such as heparin or warfarin; lack of coagulation and bleeding disorders; lack of liver and kidney disease; Ejection fraction> 35%.
Exclusion criteria: complex surgery; emergency surgery; anticoagulation therapy before surgery; having hemoglobin lower than 8 grams per deciliter before surgery.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postoperative bleeding. Timepoint: 24 hrs and 48 hrs postoperatively. Method of measurement: drainage in chest tube.
- Secondary Outcome Measures
Name Time Method